0001209191-11-033761.txt : 20110608
0001209191-11-033761.hdr.sgml : 20110607
20110608194542
ACCESSION NUMBER: 0001209191-11-033761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110606
FILED AS OF DATE: 20110608
DATE AS OF CHANGE: 20110608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRAZAN JEFFREY M
CENTRAL INDEX KEY: 0001032623
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 11901930
MAIL ADDRESS:
STREET 1: 2884 SAND HILL RD STE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
c18503_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0303
4
2011-06-06
0001080014
THERAVANCE INC
THRX
0001032623
DRAZAN JEFFREY M
BERTRAM CAPITAL
800 CONCAR DRIVE, SUITE 100
SAN MATEO
CA
94402
1
0
0
0
Common Stock
2011-06-06
2011-06-06
4
S
0
37344
23.08
D
78251
D
Common Stock
2011-06-07
2011-06-07
4
S
0
31907
23.29
D
46344
D
Represents sales of (i) 15,000 shares held personally by the Reporting Person and (ii) 22,344 shares held by Sierra Ventures Associates VI, L.P. as nominee for the Reporting Person.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.00 to $23.23 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.25 to $23.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Jeffrey M. Drazan
2011-06-07